arrow
X

Xun Chu

Dana-Farber Cancer Institute
H指数:19
被引数:5,883

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study☆

Prosigna检测试剂盒对早期HR阳性/HER2阴性乳腺癌患者新辅助治疗决策的影响:一项单中心前瞻性观察研究☆

2025-07-250
OAAI
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

TBCRC 030中三阴性乳腺癌新辅助化疗后循环肿瘤DNA与残余肿瘤负荷的关系

2023-10-0113
OAAI
A genome-wide association study identifies two new risk loci for Graves' disease
2011-08-14245
PREAI
Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease
2009-01-0642
PREAI